These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7961219)
21. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test. Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292 [TBL] [Abstract][Full Text] [Related]
22. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans. Chen HH; Liushih RN; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097 [TBL] [Abstract][Full Text] [Related]
23. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system]. Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312 [No Abstract] [Full Text] [Related]
24. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. Warnock DW; Johnson EM; Rogers TR J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472 [TBL] [Abstract][Full Text] [Related]
25. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod]. Guinet R Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739 [TBL] [Abstract][Full Text] [Related]
26. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome. Radetsky M; Wheeler RC; Roe MH; Todd JK J Clin Microbiol; 1986 Oct; 24(4):600-6. PubMed ID: 3771749 [TBL] [Abstract][Full Text] [Related]
27. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid]. Fujita S Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821 [TBL] [Abstract][Full Text] [Related]
28. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media. Siau H; Kerridge D J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162 [TBL] [Abstract][Full Text] [Related]
29. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells. Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918 [TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448 [TBL] [Abstract][Full Text] [Related]
31. In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814 [TBL] [Abstract][Full Text] [Related]
32. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp. Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870 [TBL] [Abstract][Full Text] [Related]
33. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. Hoeprich PD; Huston AC J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787 [TBL] [Abstract][Full Text] [Related]
34. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia. Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082 [TBL] [Abstract][Full Text] [Related]
35. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp. García MT; Llorente MT; Mínguez F; Prieto J Scand J Infect Dis; 2000; 32(6):669-73. PubMed ID: 11200379 [TBL] [Abstract][Full Text] [Related]
36. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts. Fromtling RA; Yu HP; Shadomy S Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology. Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. Hoeprich PD; Huston AC J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147 [TBL] [Abstract][Full Text] [Related]
39. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents. Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203 [TBL] [Abstract][Full Text] [Related]
40. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole]. Goudard M; Regli P; Buffard Y; Gabriel B Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]